Level C· Early human research exploring benefitsRetrospective StudyPubMedOpen access

Strategic application of multilayer fat grafting in facial rejuvenation: a retrospective study.

Yang R., Song Z., Wang J., Liang H.

Retrospective Study with a reported sample of 105 on Facial Rejuvenation, published in Front Surg (2026) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Retrospective Study
Journal
Front Surg (2026)
Country
Switzerland
Reported sample size
105
Source database
PubMed
PMID
41993794
PMCID
PMC13078975
DOI
10.3389/fsurg.2026.1744865

Abstract (original English)

Backgrounds Facial aging is characterized by complex volumetric changes involving soft tissue atrophy and skeletal remodeling. Autologous fat grafting has evolved as a primary technique, though unpredictable graft retention remains a challenge. Objective The study aims to provide the strategic application of differentially processed adipose products by matching material properties to anatomical requirements. Methods This retrospective study analyzed 105 patients undergoing facial fat grafting for age-related contour deformities. Adipose products, including high-density fat (HDF), adipose matrix complex (AMC), and stromal vascular fraction gel (SVF-gel), were injected into specific anatomical layers. Outcome assessments included clinical evaluation and standardized photographic documentation, Visual Analog scale, and Global Aesthetic Improvement Scale. Results All patients achieved significant aesthetic improvement with no major complications. Early side effects resolved spontaneously within 3 weeks. Sixteen patients required secondary procedures due to partial volume absorption. SVF-gel demonstrated efficacy in periorbital rejuvenation and skin quality enhancement, while HDF and AMC provided stable structural support in deeper facial regions. Patient-reported satisfaction scores were 5.26 ± 1.84 preoperatively and 8.01 ± 1.09 postoperatively. Observer assessments using the Glob

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • Without an adequate control group, treatment effects cannot be separated from other factors.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research